The Secret to 11.8% Annual Returns with Monthly Dividends

Brett Owens, Chief Investment Strategist
Updated: November 28, 2025

Monthly bills are no problem for careful contrarian readers banking 9.1% yields in monthly divvies. Let’s discuss this rare but excellent dividend breed, the company or fund that pays monthly instead of quarterly.

Only 6% of dividend payers dish monthly. The rest are quarterly or annually, which will likely not be in time to cover your upcoming cell phone bill.

My monthly email from carrier Verizon arrives in a day or two. Another $267.26 will be debited from my account automatically on the 20th.

Fortunately, Verizon notes that there is “nothing I need to do” thanks to AutoPay. As if the automatic payment implies it costs any less money!… Read more

Why I Hate Bitcoin (Hint: 0% Dividends) and What I’m Buying Instead

Michael Foster, Investment Strategist
Updated: November 27, 2025

I often get asked about crypto. My response often surprises people: I don’t spend a lot of time thinking about it.

That might sound odd given crypto’s massive popularity (though many holders are no doubt regretting their buys these days, given the swan dive Bitcoin and its ilk have been on).

Nope, I avoid Bitcoin because I (and readers of my are interested in dividend income. And you won’t find any of that in crypto. Plus it’s far more volatile than we’d like. All of this is why, when we want tech exposure, we look to CEFs holding top-quality tech stocks.… Read more

Backdoor AI Beneficiary Yields 8.8%, Trades at 13% Discount

Brett Owens, Chief Investment Strategist
Updated: November 26, 2025

Drug development will never be the same! AI is compressing time-to-market and extending the sales calendar for pharma. More profits from new medications. More new medications, too.

Many pharma and biotech stocks will boom as we enter the “sci-fi” stage of research and development. And this elite 8.8% dividend will directly benefit.

It typically takes 10 to 15 years to develop a new drug. Every month matters because patents last only 20 years. The faster a company gets a drug to market, the more months and years it enjoys with monopoly pricing power.

When patents expire, the generic versions hit the market.… Read more

These 2 “ETF Clones” Pay Up to 9.7% (and Are Perfect “Dip Buys”)

Brett Owens, Chief Investment Strategist
Updated: November 25, 2025

Our favorite dividends are now on sale—but we still need to make sure we’re buying this dip the right way.

That means zeroing in on rich payers that not only throw off big divvies, but cushion our downside, too.

I’ve got two closed-end funds (CEFs) for you that do just that—and throw off rich 7%+ yields, too. And they avoid the deadly mistake most investors are making now.

Index Funds Pay Little, “Bargain” Techs Even Less

That mistake? Most investors are looking to beaten-down tech stocks (which pay zilch—or close to it!) or they’re grabbing a “plain vanilla” index fund, like the SPDR S&P 500 ETF Trust (SPY)—current yield: 1.1%

One-point-one-percent!Read more

2 Popular CEFs: One Dangerous Gamble, One 9.9%-Paying Winner

Michael Foster, Investment Strategist
Updated: November 24, 2025

It never ceases to amaze me how many investors confuse investing with straight-up gambling.

Of course, we income investors know that gambling is a one-way ticket to losses (the house always wins, after all!). That’s why we always focus on long-term wealth creation (and a solid income stream) at my CEF Insider service, whose portfolio yields nearly 10% on average as I write this.

Nonetheless, with stocks having soared the way they have, it’s easier, even for normally prudent investors, to get caught up in dangerous speculation. That’s especially true when gambling seems to be everywhere these days.

Even though—a funny aside—gambling actually hasn’t grown as a percentage of Americans’ earnings in the last 25 years.… Read more

4 Dividends up to 20% Wall Street Can’t Stand

Brett Owens, Chief Investment Strategist
Updated: November 21, 2025

We contrarians follow Wall Street analysts because we like to fade their opinions!

When most say Buy, we are cautious. There is nobody left to upgrade these shares.

When they slap a Sell label, we are intrigued. So you’re saying the next rating change will be an upgrade?

These slippery suits rate most stocks Buys because, well, that’s the business. As we speak, 400 of the S&P 500 (!) is rated a Buy!

Even at All-Time Highs, Analysts Say 80% of the Market Is a Buy!

Source: S&P Global Market Intelligence

So let’s sift through the Holds and the Sells. Today we’ll sort through a four-pack yielding between 7.9% and 20.6%.… Read more

The Housing “Crisis,” the AI “Bubble” and the Real Market Signal No One Talks About

Michael Foster, Investment Strategist
Updated: November 20, 2025

I’ve seen a lot more news stories trying to do something that seems a bit weird these days: stoke anger between generations.

I bring this up because it’s an example of why, when it comes to picking stocks (and 8%+ paying closed-end funds), we simply can’t trust the media anymore.

Why? Because many outlets are so focused on generating emotional responses (and the clicks that go with them) that they’ve gotten far away from what really matters: the real data behind what they’re saying.

With that in mind, we’re going to look at a data-driven indicator that tells us whether or not it’s a good time to buy.… Read more

Wall Street Panics, Powell Cooks, Chef’s Kiss for THIS 12.9% Dividend

Brett Owens, Chief Investment Strategist
Updated: November 19, 2025

Jerome Powell is preparing a wonderful holiday income dish for us.

The economy is running hot and he’s cutting rates anyway. Oh baby! “Lame Duck Jerry” is finally starting to cook.

But vanilla investors aren’t having it. They’re sprinting from the table! Recession fears dominate the headlines, even though the data scream otherwise.

The Atlanta Fed’s thermometer has GDP at a sizzling 4%. Four percent! In today’s AI-fueled, efficiency-obsessed economy, the old recession playbook simply doesn’t apply.

AI is eating traditional white-collar work. Business models from 2019 no longer apply in 2025. Some sectors are struggling while others hit new strides.… Read more

This “Bubble Fear” Is the Best Setup We’ve Had in Years. These 6%+ Divvies Are the Play

Brett Owens, Chief Investment Strategist
Updated: November 18, 2025

What a time to be a contrarian!

The economy is en fuego as AI boosts productivity (even if, yes, it’s cooling payrolls). Yet the mainstream crowd is hunkered down, terrified of an AI bubble.

That sets up some very attractive deals in 8%-paying closed-end funds (CEFs), many of which have gone on sale in the last few weeks.

2 “North Stars” Show Us What to Do Now

To get a feel for the setup in front of us, all we need to do is look at two things.

First, the Atlanta Fed’s GDPNow indicator, the most current economic “barometer” we have.… Read more

If You Missed This 8% Dividend 5 Years Ago, It’s Cheap AGAIN

Michael Foster, Investment Strategist
Updated: November 17, 2025

It’s been a long time since we talked about pandemic bargains, but believe it or not, there’s still a big one out there.

I do think it’s finally on borrowed time, though, which is why it’s on our radar now.

I’m talking about publicly traded real estate investment trusts (REITs). What we’re looking at with REITs is a classic “buy the dip” play with a (very!) long buy window indeed. Here’s a snapshot:

REITs Trail Stocks Post-Pandemic …

Over the five years since the depths of the pandemic, the S&P 500 (shown by the popular index fund in purple above) has posted a 106.5% total return, as of this writing.… Read more